116 related articles for article (PubMed ID: 16124358)
1. Angiotensin-II behaves as an endogenous pro-inflammatory molecule.
Das UN
J Assoc Physicians India; 2005 May; 53():472-6. PubMed ID: 16124358
[TBL] [Abstract][Full Text] [Related]
2. Is angiotensin-II an endogenous pro-inflammatory molecule?
Das UN
Med Sci Monit; 2005 May; 11(5):RA155-162. PubMed ID: 15874906
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II as a pro-inflammatory mediator.
Phillips MI; Kagiyama S
Curr Opin Investig Drugs; 2002 Apr; 3(4):569-77. PubMed ID: 12090726
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade.
Dandona P; Dhindsa S; Ghanim H; Chaudhuri A
J Hum Hypertens; 2007 Jan; 21(1):20-7. PubMed ID: 17096009
[TBL] [Abstract][Full Text] [Related]
5. Renal and vascular hypertension-induced inflammation: role of angiotensin II.
Ruiz-Ortega M; Esteban V; Rupérez M; Sánchez-López E; Rodríguez-Vita J; Carvajal G; Egido J
Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):159-66. PubMed ID: 16481883
[TBL] [Abstract][Full Text] [Related]
6. How to explain the differences between renin angiotensin system modulators.
Levy BI
Am J Hypertens; 2005 Sep; 18(9 Pt 2):134S-141S. PubMed ID: 16125050
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of angiotensin II interruption: evidence for antiinflammatory actions.
Dagenais NJ; Jamali F
Pharmacotherapy; 2005 Sep; 25(9):1213-29. PubMed ID: 16164395
[TBL] [Abstract][Full Text] [Related]
8. [Clinical pharmacology of angiotensin II receptor antagonists].
Hitzenberger G
Wien Med Wochenschr; 2001; 151(7-8):151-2. PubMed ID: 11450161
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin converting enzyme inhibitors as potential cognitive enhancing agents.
Domeney AM
J Psychiatry Neurosci; 1994 Jan; 19(1):46-50. PubMed ID: 8148365
[TBL] [Abstract][Full Text] [Related]
10. Does reversal of oxidative stress and inflammation provide vascular protection?
Koh KK; Oh PC; Quon MJ
Cardiovasc Res; 2009 Mar; 81(4):649-59. PubMed ID: 19098298
[TBL] [Abstract][Full Text] [Related]
11. The regulation of the inflammatory response through nuclear factor-kappab pathway by angiotensin IV extends the role of the renin angiotensin system in cardiovascular diseases.
Ruiz-Ortega M; Esteban V; Egido J
Trends Cardiovasc Med; 2007 Jan; 17(1):19-25. PubMed ID: 17210474
[TBL] [Abstract][Full Text] [Related]
12. Effects of central injection of angiotensin-converting-enzyme inhibitor and angiotensin type 1 receptor antagonist on the brain NF-kappaB and AP-1 activities of rats given LPS.
Watanabe K; Taniguchi M; Miyoshi M; Shimizu H; Imoto T; Sato K; Watanabe T
Peptides; 2006 Jun; 27(6):1538-46. PubMed ID: 16356591
[TBL] [Abstract][Full Text] [Related]
13. Clinical evidence for the cardiovascular benefits of angiotensin receptor blockers.
Nickenig G; Ostergren J; Struijker-Boudier H
J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7 Suppl 1():S1-7. PubMed ID: 16969748
[TBL] [Abstract][Full Text] [Related]
14. Role of angiotensin receptor blockers in the prevention and treatment of arrhythmias.
Garg S; Narula J; Marelli C; Cesario D
Am J Cardiol; 2006 Mar; 97(6):921-5. PubMed ID: 16516603
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
[TBL] [Abstract][Full Text] [Related]
16. An update on non-peptide angiotensin receptor antagonists and related RAAS modulators.
Aulakh GK; Sodhi RK; Singh M
Life Sci; 2007 Aug; 81(8):615-39. PubMed ID: 17692338
[TBL] [Abstract][Full Text] [Related]
17. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation.
Richter B; Derntl M; Marx M; Lercher P; Gössinger HD
Am Heart J; 2007 Jan; 153(1):113-9. PubMed ID: 17174648
[TBL] [Abstract][Full Text] [Related]
18. Renin-angiotensin system mediators and Raynaud's phenomenon.
Wood HM; Ernst ME
Ann Pharmacother; 2006 Nov; 40(11):1998-2002. PubMed ID: 17003081
[TBL] [Abstract][Full Text] [Related]
19. From mitochondria to disease: role of the renin-angiotensin system.
de Cavanagh EM; Inserra F; Ferder M; Ferder L
Am J Nephrol; 2007; 27(6):545-53. PubMed ID: 17785964
[TBL] [Abstract][Full Text] [Related]
20. The therapeutic role of RAS blockade in chronic heart failure.
Werner CM; Böhm M
Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):167-77. PubMed ID: 19124420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
